| [1] American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society, 2012.[2] Maddalena B, Armando F, Massimo R, Salvatore G, Walter M, Malorni GP. Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology. Cell Physiol, 2011, 226(9): 2213-2214.[3] Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 2010, 28(10): 1721-1726.[4] Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn, 2010, 10(3): 297-308.[5] Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther, 2009, 9(6): 703-711.[6] Wang QZ, Xu W, Habib N, Xu R. Potential uses of mi-croRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets, 2009, 9(4): 572-594.[7] Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem, 2010, 56(11): 1733-1741.[8] Zubakov D, Boersma AWM, Choi Y, van Kuijk PF, Wiemer EAC, Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med, 2010, 124(3): 217-226.[9] Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem, 2009, 387(2): 303-314.[10] Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs inde-pendent of vesicles in human plasma. Proc Natl Acad Sci USA, 2011, 108(12): 5003-5008.[11] Hunter MP, Ismail N, Zhang XL, Aguda BD, Lee EJ, Yu LL, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana- Sinkam SP, Jarijoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesi-cles. PLoS One, 2008, 3(11): e3694.[12] Hadi V, Karin E, Apostolos B, Margareta S, James JL, Jan OL. Exosome-mediated transfer of mRNAs and microR-NAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007, 9(6): 654-659.[13] Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol, 2008, 110(1): 13-21.[14] Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, Wang MX. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol, 2011, 4(6): 575-586.[15] Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multive-sicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol, 2009, 11(9): 1143-1149.[16] Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracel-lular microRNA: A new source of biomarkers. Mutat Res, 2011, 717(1-2): 85-90.v[17] Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105(30): 10513-10518.[18] Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res, 2009, 15(17): 5473-5477.[19] Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2 |
